CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Comparison of Bone Mineral Density and Markers of Bone Turnover in Osteoporotic Women after 6-Month Treatment with Alendronate or Bazedoxifene: A Randomized Controlled Trial
Hee Soo Han, Sung Hee Cho, Moon Seok Park, Ki Hyuk Sung, Kyoung Min Lee
jbm. 2021;28(2):131-137.   Published online May 31, 2021
DOI: https://doi.org/10.11005/jbm.2021.28.2.131

Excel Download

Comparison of Bone Mineral Density and Markers of Bone Turnover in Osteoporotic Women after 6-Month Treatment with Alendronate or Bazedoxifene: A Randomized Controlled Trial
Journal of Bone Metabolism. 2021;28(2):131-137   Crossref logo
Link1 Link2 Link3

The efficacy and tolerability of risedronate on bone mineral density and bone turnover markers in osteoporotic Chinese women: a randomized placebo-controlled study
Bone. 2005;36(2):358-364   Crossref logo
Link1 Link2

RETRACTED ARTICLE: Effect of alendronate on bone mineral density and bone turnover markers in post-gastrectomy osteoporotic patients
Journal of Bone and Mineral Metabolism. 2009;28(2):202-208   Crossref logo
Link1 Link2 Link3 Link4

Serum adiponectin, bone mineral density and bone turnover markers in post-menopausal women with newly diagnosed Type 2 diabetes: a 12-month follow-up
Diabetic Medicine. 2011;29(1):62-69   Crossref logo
Link1 Link2

Denosumab Treatment Effects on Structural Damage, Bone Mineral Density, and Bone Turnover in Rheumatoid Arthritis: A Twelve-Month, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Clinical Trial
Yearbook of Medicine. 2009;2009:12-13   Crossref logo
Link1 Link2

Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis
Advances in Therapy. 2006;23(6):842-853   Crossref logo
Link1 Link2 Link3

Bone Histomorphometry of Transiliac Paired Bone Biopsies After 6 or 12 Months of Treatment With Oral Strontium Ranelate in 387 Osteoporotic Women: Randomized Comparison to Alendronate
Journal of Bone and Mineral Research. 2014;29(3):618-628   Crossref logo
Link1 Link2

90 CHANGE OF BONE MINERAL DENSITY AFTER ONE-YEAR ALENDRONATE TREATMENT IN PREMENOPAUSAL WOMEN WITH LOW BONE DENSITY
Maturitas. 2012;71:S49   Crossref logo
Link1 Link2

Bone mineral density and bone turnover markers after 12 months and 18 months of teriparatide in Korean women with prior antiresorptive treatment
Bone. 2010;47:S208   Crossref logo
Link1 Link2

Effect of osteoporosis medication on changes in bone mineral density and bone turnover markers after 24-month administration of daily teriparatide: comparison among minodronate, raloxifene, and eldecalcitol
Journal of Bone and Mineral Metabolism. 2017;36(2):221-228   Crossref logo
Link1 Link2 Link3